| Expression pattern: |
DN |
| Associated gene: |
Smad7, TGFbeta, Smad2/3 |
| Associated microRNA: |
miR-21-5p |
| Biological function: |
Promotes osteogenic differentiation and proliferation and inhibits apoptosis of GC-treated BMSCs; attenuates osteonecrosis in SIONFH rats. |
| Molecular mechanism: |
Acts as a ceRNA sponging miR-21-5p to upregulate Smad7 and inhibit GC-activated TGFbeta/Smad2/3 signaling. |
| Biological pathway or process: |
TGF-beta/SMAD (inhibits); apoptosis (inhibits); proliferation (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Luciferase Reporter Assay; RNA Pull-Down; Transfection; BrdU; Annexin V/PI Flow Cytometry; Western Blot; IHC (Immunohistochemistry); H&E Staining; In Vivo Animal Model; Bioinformatics Analysis |
| Clinical significance: |
- |
| Description: |
CircPVT1 is down-regulated in SIONFH models. Its overexpression protects against steroid/GC-induced osteonecrosis phenotypes by promoting osteogenic differentiation and proliferation while inhibiting apoptosis. Mechanistically, CircPVT1 sponges miR-21-5p to increase Smad7 and suppress TGFbeta/Smad2/3 signaling. |
| Confidence score: |
0.7045 |